Unknown

Dataset Information

0

Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model.


ABSTRACT: The increased cancer mortality of diabetes type 2 patients is most likely an evidence of the tight connection between tumor development and energy metabolism. A major focus of today's research is still the identification of key proteins of both diseases and the development of corresponding inhibitors. In this study we combined the two-stage BALB/c-3T3 cell transformation assay (BALB-CTA) with the IR/IGF-1R inhibitor OSI-906 (linsitinib) and analyzed alterations in protein activity and energy parameters in non-transformed as well as transformed cells. OSI-906 successfully inhibited the phosphorylation of IR/IGF-1R and decreased cell growth in non-transformed cells. In the BALB-CTA, a permanent treatment with OSI-906 reduced cellular transformation dose-dependently, whereas a temporary treatment gave evidence for a preventive effect in the promotion phase. Furthermore, even though several key proteins were affected, it was possible to show that the phosphorylation of GSK3, Erk 1/2 and the S6 protein are not crucial for the cell foci reducing effect of OSI-906. Taken together, the BALB-CTA confirmed results of OSI-906 from animal studies and enhanced the knowledge of its mode of action. Therefore, the BALB-CTA offers the opportunity to analyze alterations in the transformation process more precisely and will be helpful to identify effective cancer treatments.

SUBMITTER: Poburski D 

PROVIDER: S-EPMC5111065 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model.

Poburski Doerte D   Leovsky Christiane C   Boerner Josefine Barbara JB   Szimmtenings Luisa L   Ristow Michael M   Glei Michael M   Thierbach René R  

Scientific reports 20161116


The increased cancer mortality of diabetes type 2 patients is most likely an evidence of the tight connection between tumor development and energy metabolism. A major focus of today's research is still the identification of key proteins of both diseases and the development of corresponding inhibitors. In this study we combined the two-stage BALB/c-3T3 cell transformation assay (BALB-CTA) with the IR/IGF-1R inhibitor OSI-906 (linsitinib) and analyzed alterations in protein activity and energy par  ...[more]

Similar Datasets

| S-EPMC5017208 | biostudies-literature
| S-EPMC4049074 | biostudies-literature
| S-EPMC2751744 | biostudies-literature
2024-05-20 | GSE256186 | GEO
| S-EPMC6319485 | biostudies-literature
| S-EPMC3448087 | biostudies-other
| S-EPMC3026833 | biostudies-literature
| S-EPMC5520495 | biostudies-literature
| S-EPMC5575806 | biostudies-literature
2013-06-01 | E-GEOD-40573 | biostudies-arrayexpress